EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Chronic glial activation and behavioral alterations induced by acute/subacute pioglitazone treatment in a mouse model of traumatic brain injury

L Daniel Estrella, Jane E Manganaro, Lexi Sheldon, Nashanthea Roland, Austin D Snyder, Joseph W George, Katy Emanuel, Benjamin G Lamberty, Kelly L Stauch

Brain, Behavior, and Immunity · 2025

DOI: 10.1016/j.bbi.2024.09.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, Behavior, and Immunity, 2025. Verfasst von L Daniel Estrella und 8 weiteren Autor:innen. Beteiligte Einrichtung: University of Nebraska Medical Center, College of Medicine, Department of Neurological Sciences, Omaha, NE, USA. Hauptthemen laut MEDLINE: Pioglitazone, Brain Injuries, Traumatic, Disease Models, Animal, Neuroglia. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: US Department of Defense, Congressionally Directed Medical Research Programs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Traumatic brain injury (TBI) is a disabling neurotraumatic condition and the leading cause of injury-related deaths and disability in the United States. Attenuation of neuroinflammation early after TBI is considered an important treatment target; however, while these inflammatory responses can induce secondary brain injury, they are also involved in the repair of the nervous system. Pioglitazone, which activates peroxisome proliferator-activated receptor gamma, has been shown to decrease inflammation acutely after TBI, but the long-term consequences of its use remain unknown. For this reason, the impacts of treatment with pioglitazone during the acute/subacute phase (30 min after injury and each subsequent 24 h for 5 days) after TBI were interrogated during the chronic phase (30- and 274-days post-injury (DPI)) in mice using the controlled cortical impact model of experimental TBI. Acute/subacute pioglitazone treatment after TBI results in long-term deleterious consequences, including disruption of tau homeostasis, chronic glial cell activation, neuronal pathology, and worsened injury severity particularly at 274 DPI, with male mice being more susceptible than female mice. Further, male pioglitazone-treated TBI mice exhibited increased dominant and offensive-like behavior while having a decreased non-social exploring behavior at 274 DPI. After TBI, both sexes exhibited glial activation at 30 DPI when treated with pioglitazone; however, while injury severity was increased in females it was not impacted in male mice. This work reveals that although pioglitazone has been shown to lead to attenuated TBI outcomes acutely, sex-based differences, timing and long-term consequences of treatment with glitazones must be considered and further studied prior to their clinical use for TBI therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PioglitazoneBrain Injuries, TraumaticDisease Models, AnimalNeurogliaAnimalsMiceMaleFemaleMice, Inbred C57BLBehavior, AnimalPPAR gammaBrainNeuronsNeuroinflammatory Diseases

Stichwörter der Autor:innen

Aggressive behaviorAstrogliosisChronic phase of TBIDominant behaviorMicrogliosisNeuroinflammationPeroxisome proliferator-activated receptor gamma (PPAR-γ)Phosphorylated TauPioglitazoneTraumatic brain injury (TBI)

Substanzen

PioglitazonePPAR gamma

Autor:innen und Institutionen

  • University of Nebraska Medical Center, College of Medicine, Department of Neurological Sciences, Omaha, NE, USA.
  • University of Nebraska Medical Center, College of Medicine, Department of Neurological Sciences, Omaha, NE, USA. Electronic address: kelly.stauch@unmc.edu.

Förderung

  • US Department of Defense
  • Congressionally Directed Medical Research Programs

Zitieren

APA

Estrella, L. D., Manganaro, J. E., Sheldon, L., Roland, N., Snyder, A. D., George, J. W., Emanuel, K., Lamberty, B. G., & Stauch, K. L. (2025). Chronic glial activation and behavioral alterations induced by acute/subacute pioglitazone treatment in a mouse model of traumatic brain injury. Brain, Behavior, and Immunity. https://doi.org/10.1016/j.bbi.2024.09.006

Vancouver

Estrella LD, Manganaro JE, Sheldon L, Roland N, Snyder AD, George JW, et al. Chronic glial activation and behavioral alterations induced by acute/subacute pioglitazone treatment in a mouse model of traumatic brain injury. Brain, Behavior, and Immunity. 2025. doi:10.1016/j.bbi.2024.09.006

BibTeX
@article{Estrella2025,
  author = {Estrella, L Daniel and Manganaro, Jane E and Sheldon, Lexi and Roland, Nashanthea and Snyder, Austin D and George, Joseph W and Emanuel, Katy and Lamberty, Benjamin G and Stauch, Kelly L},
  title = {Chronic glial activation and behavioral alterations induced by acute/subacute pioglitazone treatment in a mouse model of traumatic brain injury},
  journal = {Brain, Behavior, and Immunity},
  year = {2025},
  doi = {10.1016/j.bbi.2024.09.006}
}
Kostenlos starten →